Terms ending in 2035

Array Biopharma Inc.

Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.

Patent	Title	Holder	Status	Expires	Confidence
US 9,763,942	Serine/Threonine Kinase Inhibitors Genentech, Inc. In force Term ends Feb 8, 2035 · High confidence	Genentech, Inc.	In force	Term ends Feb 8, 2035	High confidence
US 10,351,575	Bicyclic Urea, Thiourea, Guanidine and Cyanoguanidine Compounds Useful for the Treatment of Pain Array Biopharma Inc. In force Term ends Jul 18, 2035 · High confidence	Array Biopharma Inc.	In force	Term ends Jul 18, 2035	High confidence
US 9,782,414	Crystalline Form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide Hydrogen Sulfate Array Biopharma, Inc. In force Term ends Nov 16, 2035 · High confidence	Array Biopharma, Inc.	In force	Term ends Nov 16, 2035	High confidence
US 10,172,861	Crystalline Form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide Hydrogen Sulfate Array Biopharma Inc. In force Term ends Nov 16, 2035 · High confidence	Array Biopharma Inc.	In force	Term ends Nov 16, 2035	High confidence
US 10,285,993	Crystalline Form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide Hydrogen Sulfate Array Biopharma, Inc. In force Term ends Nov 16, 2035 · High confidence	Array Biopharma, Inc.	In force	Term ends Nov 16, 2035	High confidence
US 10,813,936	Crystalline Form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide Hydrogen Sulfate Array Biopharma, Inc. In force Term ends Nov 16, 2035 · High confidence	Array Biopharma, Inc.	In force	Term ends Nov 16, 2035	High confidence
US 10,189,845	4,6-Substituted-pyrazolo[1,5-a]pyrazines as Janus Kinase Inhibitors Array Biopharma Inc. In force Term ends Dec 4, 2035 · High confidence	Array Biopharma Inc.	In force	Term ends Dec 4, 2035	High confidence
US 10,730,880	4,6-Substituted-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS Array Biopharma Inc. In force Term ends Dec 4, 2035 · High confidence	Array Biopharma Inc.	In force	Term ends Dec 4, 2035	High confidence
US 11,028,093	4,6-Substituted-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS Array BioPharma Inc. In force Term ends Dec 4, 2035 · High confidence	Array BioPharma Inc.	In force	Term ends Dec 4, 2035	High confidence

9 of 9 patents shown. Soonest term end first, then patent number.

8 of these are in force and held by Array Biopharma Inc..

Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.